Phosphodiesterase 4 Inhibitors and the Treatment of Asthma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Reference199 articles.
1. Prevalence of asthma and hay fever in England and Wales.
2. Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81.
3. HAS THE MANAGEMENT OF ASTHMA IMPROVED?
Cited by 150 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PDE4阻害薬（ジファミラスト軟膏）;Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology;2023-12-20
2. Ethnopharmacological basis and pharmacodynamics prospectives for folkloric claims of Rosa webbiana wall. Ex. Royle in diarrhea and asthma via In vitro, In vivo and In silico techniques;Journal of Ethnopharmacology;2023-12
3. An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022;Molecules;2022-08-04
4. An Open-Label, Randomized, Prospective, Comparative, Three-Arm Clinical Trial to Evaluate the Safety and Effectiveness of Apremilast with Three Different Titration Methods in Patients with Chronic Plaque Psoriasis in India;Psoriasis: Targets and Therapy;2022-04
5. Vinpocetine alleviates lung inflammation via macrophage inflammatory protein-1β inhibition in an ovalbumin-induced allergic asthma model;PLOS ONE;2021-04-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3